Clinical trial
Reducing Transition Drug Risk
NCT00370916 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00370916 |
|---|---|
| Title | Reducing Transition Drug Risk |
| Official title | Reducing Transition Drug Risks After Patient Transfer |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | University of Victoria Icahn School of Medicine at Mount Sinai |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hospitalization |
| Intervention type | Behavioral |
| Interventions | Physician-initiated medication reconciliation, Pharmacist-initiated medication reconciliation |
| Enrollment | 612 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2006 |
| Completion | Sep 1, 2010 |
| First posted | Sep 1, 2006 |
| Last update posted | Apr 7, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: